knowt logo

VM 536 Day 8 Small Airway Small Animal post class 2021

Gandalf: Feline Asthma Case Overview

Case Presentation

  • Patient: Gandalf, 8-year-old Neutered Domestic Longhair (DLH)

  • Chief Complaint: Persistent cough for 6 months; miscommunication regarding the purpose of the appointment.

Patient History

  • Source: Rescued from a Humane Society

  • Household: Lives with one dog; single cat household

  • Lifestyle: Indoor/outdoor access

  • Symptoms:

    • "Always coughs a bit"

    • Episodes of orthopnea and open-mouth breathing after play or outdoor activity

    • Otherwise appears healthy

  • Vaccination Status: Up to date with FVRCP, FeLV, Rabies, flea, and tick preventive.

Physical Examination

  • Vital Signs:

    • Temperature: 99.5°F (normal range 100.5 - 103°F)

    • Pulse: 180 bpm (normal range 120 - 220 bpm)

    • Respiratory Rate: 40 bpm (normal range 16 - 32 bpm)

    • CRT: <2s, mucous membranes pink.

  • Auscultation Findings:

    • Notable expiratory effort

    • Bronchovesicular sounds and occasional expiratory wheezes

  • Body Condition Score: 6/9, weight at 12 lbs.

Initial Laboratory Testing

  • Results:

    • CBC: Normal

    • Chemistry: Normal

    • Urinalysis: Normal

Problem List

  • History:

    • Cough

    • Episodic orthopnea

  • Physical Exam Findings:

    • Expiratory effort

    • Loud bronchovesicular sounds

    • Expiratory wheezes

    • Overweight status (BCS 6/9)

  • Differential Diagnoses: Investigation ongoing.

Diagnostic Plan

  • Planned Diagnostics:

    • Thoracic radiographs

    • Fecal flotation

    • Heartworm test

Radiographic Findings

  • Thoracic Radiographs:

    • Mild, diffuse bronchial/bronchiolar pattern observed

    • Mild aerophagia noted

Additional Diagnostic Results

  • Fecal Examinations:

    • Flotation: Negative

    • Sedimentation: Negative

    • Baermann: Negative

  • Heartworm Antibody Test: Negative

  • Other Tests: Aelurostrongylus abstrusus larvae and Snap Feline Triple test performed.

Importance of Problem List

  • Chronic Cough Causes:

    • Heartworm disease

    • Chronic bronchitis

    • Asthma

    • Bronchopneumonia

    • Pulmonary parasites

    • Foreign bodies

    • Neoplasia

  • Dynamic Lower Airway Disease Indicators:

    • Asthma

    • Chronic bronchitis

    • Heart disease

    • Neoplasia

  • Radiographic Patterns:

    • Indicative of asthma or bronchitis (chronic, viral, etc) or neoplasia.

Anesthetic Protocol for Tracheobronchoscopy

  • Preparation: Fasted overnight

  • Medications:

    • Terbutaline (0.6 mg SQ) - beta-adrenergic agonist

    • Propofol - Short-acting injectable anesthetic

    • Pre-oxygenation prior to procedure.

Bronchoalveolar Lavage (BAL) Cytology Findings

  • Cell Type Distribution:

    • Eosinophils: 75%

    • Macrophages: 15%

    • Neutrophils: 10%

    • Squamous epithelial cells present

    • Ciliated columnar epithelial cells present.

Pathophysiology of Feline Asthma

  • Clinical Signs Associated with Persistent Inflammation:

    • Chronic cough

    • Bronchoconstriction

    • Mucus hypersecretion

    • Airway obstruction

  • Morphological Changes:

    • Mucous cell metaplasia

    • Smooth muscle hypertrophy

    • Change from reversible to irreversible obstruction.

Acute Control of Inflammation

  • Medications:

    • Short-acting corticosteroids (Dexamethasone) for emergency therapy, advantages include bioavailability, cost, and speed of action.

    • Consideration for additional respiratory support: oxygen therapy and bronchodilators (Terbutaline 0.01 mg/kg IV, SQ).

Chronic Control of Inflammation

  • Medications:

    • Oral prednisolone (2 mg/kg/day divided BID), tapering to lowest effective dose.

    • Inhaled glucocorticoids (Fluticasone propionate) for less systemic effects but may be expensive and have a learning curve.

Metered Dose Inhaler (MDI) Therapy

  • Purpose: Deliver glucocorticoids and bronchodilators for chronic airway disease.

  • Features:

    • Designed to aerosolize medications for optimum deposition in airways.

    • Spacer device enhances efficacy of drug delivery.

Monitoring Treatment Efficacy

  • Initial Evaluation:

    • Monitoring cough counts, resting respiratory rate, and general activity.

  • If Ineffective:

    • Screen for complications and other co-morbidities.

    • Adjust anti-inflammatory therapy or consider bronchodilators.

Right Middle Lung Syndrome

  • Characteristics:

    • Recurrent collapse of right middle lung; common in asthma and chronic bronchitis.

  • Factors Influencing Syndrome:

    • Anatomical (narrow lobar bronchus, gravity effects)

    • Pathological (mucus hypersecretion, bronchospasm).

  • Clinical Signs: Persistent cough and bronchial inflammation even with treatment.

VM 536 Day 8 Small Airway Small Animal post class 2021

Gandalf: Feline Asthma Case Overview

Case Presentation

  • Patient: Gandalf, 8-year-old Neutered Domestic Longhair (DLH)

  • Chief Complaint: Persistent cough for 6 months; miscommunication regarding the purpose of the appointment.

Patient History

  • Source: Rescued from a Humane Society

  • Household: Lives with one dog; single cat household

  • Lifestyle: Indoor/outdoor access

  • Symptoms:

    • "Always coughs a bit"

    • Episodes of orthopnea and open-mouth breathing after play or outdoor activity

    • Otherwise appears healthy

  • Vaccination Status: Up to date with FVRCP, FeLV, Rabies, flea, and tick preventive.

Physical Examination

  • Vital Signs:

    • Temperature: 99.5°F (normal range 100.5 - 103°F)

    • Pulse: 180 bpm (normal range 120 - 220 bpm)

    • Respiratory Rate: 40 bpm (normal range 16 - 32 bpm)

    • CRT: <2s, mucous membranes pink.

  • Auscultation Findings:

    • Notable expiratory effort

    • Bronchovesicular sounds and occasional expiratory wheezes

  • Body Condition Score: 6/9, weight at 12 lbs.

Initial Laboratory Testing

  • Results:

    • CBC: Normal

    • Chemistry: Normal

    • Urinalysis: Normal

Problem List

  • History:

    • Cough

    • Episodic orthopnea

  • Physical Exam Findings:

    • Expiratory effort

    • Loud bronchovesicular sounds

    • Expiratory wheezes

    • Overweight status (BCS 6/9)

  • Differential Diagnoses: Investigation ongoing.

Diagnostic Plan

  • Planned Diagnostics:

    • Thoracic radiographs

    • Fecal flotation

    • Heartworm test

Radiographic Findings

  • Thoracic Radiographs:

    • Mild, diffuse bronchial/bronchiolar pattern observed

    • Mild aerophagia noted

Additional Diagnostic Results

  • Fecal Examinations:

    • Flotation: Negative

    • Sedimentation: Negative

    • Baermann: Negative

  • Heartworm Antibody Test: Negative

  • Other Tests: Aelurostrongylus abstrusus larvae and Snap Feline Triple test performed.

Importance of Problem List

  • Chronic Cough Causes:

    • Heartworm disease

    • Chronic bronchitis

    • Asthma

    • Bronchopneumonia

    • Pulmonary parasites

    • Foreign bodies

    • Neoplasia

  • Dynamic Lower Airway Disease Indicators:

    • Asthma

    • Chronic bronchitis

    • Heart disease

    • Neoplasia

  • Radiographic Patterns:

    • Indicative of asthma or bronchitis (chronic, viral, etc) or neoplasia.

Anesthetic Protocol for Tracheobronchoscopy

  • Preparation: Fasted overnight

  • Medications:

    • Terbutaline (0.6 mg SQ) - beta-adrenergic agonist

    • Propofol - Short-acting injectable anesthetic

    • Pre-oxygenation prior to procedure.

Bronchoalveolar Lavage (BAL) Cytology Findings

  • Cell Type Distribution:

    • Eosinophils: 75%

    • Macrophages: 15%

    • Neutrophils: 10%

    • Squamous epithelial cells present

    • Ciliated columnar epithelial cells present.

Pathophysiology of Feline Asthma

  • Clinical Signs Associated with Persistent Inflammation:

    • Chronic cough

    • Bronchoconstriction

    • Mucus hypersecretion

    • Airway obstruction

  • Morphological Changes:

    • Mucous cell metaplasia

    • Smooth muscle hypertrophy

    • Change from reversible to irreversible obstruction.

Acute Control of Inflammation

  • Medications:

    • Short-acting corticosteroids (Dexamethasone) for emergency therapy, advantages include bioavailability, cost, and speed of action.

    • Consideration for additional respiratory support: oxygen therapy and bronchodilators (Terbutaline 0.01 mg/kg IV, SQ).

Chronic Control of Inflammation

  • Medications:

    • Oral prednisolone (2 mg/kg/day divided BID), tapering to lowest effective dose.

    • Inhaled glucocorticoids (Fluticasone propionate) for less systemic effects but may be expensive and have a learning curve.

Metered Dose Inhaler (MDI) Therapy

  • Purpose: Deliver glucocorticoids and bronchodilators for chronic airway disease.

  • Features:

    • Designed to aerosolize medications for optimum deposition in airways.

    • Spacer device enhances efficacy of drug delivery.

Monitoring Treatment Efficacy

  • Initial Evaluation:

    • Monitoring cough counts, resting respiratory rate, and general activity.

  • If Ineffective:

    • Screen for complications and other co-morbidities.

    • Adjust anti-inflammatory therapy or consider bronchodilators.

Right Middle Lung Syndrome

  • Characteristics:

    • Recurrent collapse of right middle lung; common in asthma and chronic bronchitis.

  • Factors Influencing Syndrome:

    • Anatomical (narrow lobar bronchus, gravity effects)

    • Pathological (mucus hypersecretion, bronchospasm).

  • Clinical Signs: Persistent cough and bronchial inflammation even with treatment.

robot